MedTrace Logo

Language and Motor Skills of Preterm Infants in Pre-school Age: Diagnosis and Early Intervention

NCT01426659 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 139

Last updated 2015-06-03

No results posted yet for this study

Summary

The preterm children have more difficulty minor neurological developmental than the general population even without cerebral palsy. Their oral language difficulties of language and writing have been little studied. The investigators propose to study spoken language has 3 years 1/2 and stimulate or not (depending on randomization) children with phonological weaknesses notemment language. The investigators will evaluate stimulation protocol implied short and precise language in a re-education "say and do" in 20 sessions. A new evaluation of language (BILO and N-EEL), sensorimotor and cognitive constraints (KABC) will be performed at 4 years.

Early intervention on the basis of precise language before closing the window developmental (\<5 years) is expected to improve as a result of language and cognitive development of preterm infants.

Conditions

  • Disorder of Speech and Language Development

Interventions

BEHAVIORAL

parental stimulation according to protocol

verbal stimulation every day image of the Protocol "Dire et Faire"

Sponsors & Collaborators

  • European Regional Development Fund

    collaborator OTHER

  • University Hospital, Rouen

    lead OTHER

Principal Investigators

  • A Charollais · UH Rouen

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
34 Months
Max Age
38 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2015-02-28
Completion
2015-02-28

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01426659 on ClinicalTrials.gov